|

|
Lesson 286:
PreAnesthetic Assessment of the Patient with Goodpasture's Syndrome |
|
Course Authors:
Keri Copponex, Medical student, Louisiana State
University School of Medicine, New Orleans, Louisiana; Alan D.
Kaye, MD, PhD, Professor and chairman, Department of
Anesthesiology, Louisiana State University School of Medicine, New
Orleans, Louisiana
|
Registration Fee: $15.00
2.0 AMA PRA Category 1 CreditsTM
available until June 30, 2011
|
|
Reviewed By:
Charles J. Fox, MD, Associate professor,
Department of Anesthesiology, Tulane University School of
Medicine, New Orleans, Louisiana
|
Review Date: May, 2010 |
REGISTRATION INFORMATION:
Participants who do not possess a copy of Anesthesiology News
can download and print the course material in an easy to read
convenient format. Participants must reflect on the information
presented, and then register to complete the exam and course evaluation
online before the availability date listed above. (CME credit is not valid past this
date).
Click on the link below to download and print the course material
and post-test exam.
Register for the exam to enter your responses to receive CME credit. There are ten questions in the examination and you must achieve
a score of 80% or better to earn CME credit. Following successful
completion, your certificate will be immediately available online.
In addition, a historical record of completed CME courses is
maintained online in an individualized profile. This includes
copies of course certificates which can be printed at any time.
The registration fee for this course is $15.00
Physicians are provided with two opportunities to successfully complete the
exam presented here.
Software Requirements: Adobe Acrobat Reader and any standard
Internet Browser.
|
|
|
NEEDS STATEMENT
Goodpasture’s syndrome (GS), an autoimmune disease, presents
challenges for the anesthetic care of patients, particularly because
of effects on the respiratory and renal systems. Perioperatively,
the anesthesiologist should be able to appropriately manage these
patients. Rarely en-countered disease states have been identified as
important topics for clinical anesthesiologists.
CASE HISTORY
A 26-year-old man presented with a
5-year history of GS, confirmed by a renal biopsy. Due to his
declining renal function, placement of an arteriovenous graft for
renal dialysis was scheduled. A review of systems indicated slight
dyspnea and occasional hemoptysis. Pulmonary function tests
conducted 2 months previously indicated mild restrictive lung
disease.
LEARNING OBJECTIVES
At the end of this activity, the participant should be able to:
-
Define GS.
-
Review special problems
associated with the administration of anesthetics to
patients with GS.
-
Describe the pulmonary and
renal manifestations seen in these patients.
-
Explain the pathogenesis of
GS.
-
Apply appropriate preoperative
testing and evaluation of patients.
-
Discuss the findings of
laboratory tests.
-
Present an anesthetic and
analgesic plan for the treatment of patients with GS.
-
Discuss treatment options.
-
Cite the incidence and
prevalence of GS.
-
Anticipate, recognize, and
manage likely perioperative complications associated with
GS.
TARGET AUDIENCE: Anesthesiologists
|
|
Accreditation Statement
Mount Sinai School of Medicine is accredited by the Accreditation
Council for Continuing Medical Education (ACCME) to provide continuing
medical education for physicians.
Credit Designation: The Mount Sinai School of Medicine designates
each educational activity for a maximum of 2 AMA PRA Category 1 CreditsTM.
Physicians should only claim credit commensurate with the extent of
their participation in the activity.
It is the policy of Mount Sinai School of Medicine to ensure objectivity,
balance, independence, and scientific rigor in all CME-sponsored educational
activities. All faculty participating in the planning or implementation
of a sponsored activity are expected to disclose to the audience any
relevant financial relationships and to assist in resolving any conflict
of interest that may arise from the relationship. Presenters must
also make a meaningful disclosure to the audience of their discussions
of unlabeled or unapproved drugs or devices.
Disclosures
Dr. Kaye has disclosed that he is a member of the speakers’
bureau of Baxter. The other author, the reviewer, and the editor
have no relation-ships with pharmaceutical companies or
manufacturers of products to disclose. This educational activity
may contain discussion of published and/or investigational uses
of agents for the treatment of disease. Some uses of these
agents have not been approved by the FDA. Please refer to the
official prescribing information for each product for approved
indications, contraindications, and warnings.
CONTACT INFORMATION
Questions regarding course content may be directed to Dr. Elizabeth
Frost: ElzFrost@aol.com.
If you require technical assistance with completing this
course, please contact Continuing Education Online Customer Service
at 718-648-8080 or send e-mail to
ceo.contact7@proceo.com.
CALL FOR WRITERS
If you would like to write a CME lesson in Anesthesiology News,
please send an e-mail to Elizabeth A.M. Frost, MD, at
ElzFrost@aol.com
|
|